Trikafta (elexacaftor/tezacaftor/ivacaftor) - Vertex
Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER) (clinicaltrials.gov) - Sep 10, 2026 - P4 | N=206 | Active, not recruiting | Sponsor: Royal College of Surgeons, Ireland | Trial primary completion date: Apr 2029 ➔ Jul 2029 
Real-world evidence • Trial primary completion date • Cystic Fibrosis • Gastroenterology • Gastrointestinal Disorder • Genetic Disorders • Hepatology • Immunology • Liver Cirrhosis • Pulmonary Disease • Respiratory Diseases
http://clinicaltrials.gov/ct2/show/NCT04602468
 
Sep 10, 2026
 
Prev Next